These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Oku R; Oda S; Nakada TA; Sadahiro T; Nakamura M; Hirayama Y; Abe R; Tateishi Y; Ito M; Iseki T; Hirasawa H Cytokine; 2013 Jan; 61(1):112-7. PubMed ID: 23046618 [TBL] [Abstract][Full Text] [Related]
5. The therapeutic potential of TREM-1 modulation in the treatment of sepsis and beyond. Gibot S Curr Opin Investig Drugs; 2006 May; 7(5):438-42. PubMed ID: 16729720 [TBL] [Abstract][Full Text] [Related]
6. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Sharif O; Knapp S Immunobiology; 2008; 213(9-10):701-13. PubMed ID: 18926286 [TBL] [Abstract][Full Text] [Related]
7. Effects of aging on triggering receptor expressed on myeloid cells (TREM)-1-induced PMN functions. Fortin CF; Lesur O; Fulop T FEBS Lett; 2007 Mar; 581(6):1173-8. PubMed ID: 17336301 [TBL] [Abstract][Full Text] [Related]
8. TREM-1: a new regulator of innate immunity in sepsis syndrome. Nathan C; Ding A Nat Med; 2001 May; 7(5):530-2. PubMed ID: 11329047 [No Abstract] [Full Text] [Related]
9. Azithromycin acts as an immunomodulatory agent to suppress the expression of TREM-1 in Bacillus pyocyaneus-induced sepsis. Tong J; Liu ZC; Wang DX Immunol Lett; 2011 Aug; 138(2):137-43. PubMed ID: 21507332 [TBL] [Abstract][Full Text] [Related]